Fritz R. Buhler
Corporate Officer/Principal bei University Hospital of Boston
Profil
Fritz R.
Buhler is a Director of AGY Therapeutics, Inc. and Bear Stearns.
He is a Professor of Pharmaceutical Medicine, Pathophysiology, Internal Medicine and Cardiology at the University Hospital.
Prior to his current position, he was Director of the Department of Research at the University Hospital.
Dr. Buhler is a Director of the European Center of Pharmaceutical Medicine, the Georgetown Center of Drug Development Science, Corus Pharma, Inc., and a Co-Founder of the BioValley.
Previously, he co-founded the International Biomedicine Management Partners (IBMP) of Basel, Switzerland and served as Vice Chairman.
Dr. Buhler was Head of Global Clinical Research and Development and Chief Medical Officer of Hoffmann-La Roche, Basel from 1992 to 1995.
He was a Director of the Swiss Academy of Medical Sciences and a Visiting Professor in Cardiology at Columbia University and Harvard University.
Dr. Buhler received an MD from the University of Basel and a PhD from the University of Louis Pasteur in Strasbourg, France.
Aktive Positionen von Fritz R. Buhler
| Unternehmen | Position | Beginn |
|---|---|---|
| University Hospital of Boston | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Fritz R. Buhler
| Unternehmen | Position | Ende |
|---|---|---|
Bear Stearns Health Innoventures Management LLC
 Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Private Equity Investor | 30.09.2007 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| International Biomedicine Management Partners AG | Direktor/Vorstandsmitglied | - |
Ausbildung von Fritz R. Buhler
| University of Basel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bear Stearns Health Innoventures Management LLC
Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Finance |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| University Hospital of Boston | |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
| International Biomedicine Management Partners AG | Finance |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
